Furthermore, research conducted by Zhou et al. [31] demonstrated that naringenin enhances anticancer effects in thyroid cancer, not only by diminishing cell proliferation but also by inducing apoptosis through an alternative mechanism, specifically the inhibition of the PI3K/AKT signaling pathway. Here, AKT1 is linked to thyroid gland carcinoma.